Review



fluorescence intensity analysis  (Olympus)


Bioz Verified Symbol Olympus is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Olympus fluorescence intensity analysis
    Fluorescence Intensity Analysis, supplied by Olympus, used in various techniques. Bioz Stars score: 99/100, based on 7785 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+intensity+analysis/pm40516193-188-19-28?v=Olympus
    Average 99 stars, based on 7785 article reviews
    fluorescence intensity analysis - by Bioz Stars, 2026-07
    99/100 stars

    Images



    Similar Products

    99
    Oxford Instruments myh11 fluorescence intensity quantitative analysis employed imaris software
    Myh11 Fluorescence Intensity Quantitative Analysis Employed Imaris Software, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+intensity+analysis/pm40956620-234-0-6?v=Oxford+Instruments
    Average 99 stars, based on 1 article reviews
    myh11 fluorescence intensity quantitative analysis employed imaris software - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    99
    Sartorius AG vitro incucyte fluorescence intensity data
    Vitro Incucyte Fluorescence Intensity Data, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+intensity+analysis/pm39936977-73-2-11?v=Sartorius+AG
    Average 99 stars, based on 1 article reviews
    vitro incucyte fluorescence intensity data - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    99
    Tecan Systems fluorescence intensity analysis
    Fluorescence Intensity Analysis, supplied by Tecan Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+intensity+analysis/pmc11455939__41467_2024_52604_MOESM1_ESM-208-0-7?v=Tecan+Systems
    Average 99 stars, based on 1 article reviews
    fluorescence intensity analysis - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    99
    Olympus fluorescence intensity analysis
    Fluorescence Intensity Analysis, supplied by Olympus, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+intensity+analysis/pm40516193-188-19-28?v=Olympus
    Average 99 stars, based on 1 article reviews
    fluorescence intensity analysis - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    99
    Sartorius AG fluorescence intensity
    ( A ) Basal oxygen consumption rate measured by Seahorse MitoStress Test in untreated H9C2 cells or those treated with iCT, malonate, or their combination (n=4) Brown-Forsythe and Welch ANOVA test: ***p<0,001. ( B ) Maximum oxygen consumption rate measured by Seahorse MitoStress Test in H9C2 either untreated or treated with iCT, malonate, or the combination of iCT and malonate (Combo) for 24 hours (n=4) Brown-Forsythe and Welch ANOVA test. ( C ) ATP production measured by Seahorse MitoStress Test in H9C2 cells either untreated or treated with iCT, malonate, or the combination of iCT and malonate (Combo) for 24 hours (n=6). Friedman Test, *p<0,05; **p<0,01. ( D ) Histogram of NAD + concentration in H9C2 cells, either untreated or treated with iCT, malonate, or their combination (n=6). One-way ANOVA. ( E ) Histogram of NADH concentration in H9C2 cells, either untreated or treated with iCT, malonate, or their combination (n=6). One-way ANOVA: **p<0,01. ( F ) Histogram of succinate concentration in H9C2 cells treated with iCT, Malonate, or the combination of Malonate and iCT, normalized to control cells (n=4). One sample t-test, *p<0,05; **p<0.01. ( G ) Kinetics and ( H ) Histogram quantification of Mitosox Green <t>fluorescence</t> representing mitochondrial ROS before and after pre-treating H9C2 cells with malonate, followed by iCT treatment, or after iCT treatment alone (n=6). One-way ANOVA: *p<0.05; **p<0.01 ( I ) Histogram of viable H9C2 cell counts, comparing untreated cells to those treated with iCT, S3QEL2, or a combination of iCT and S3QEL2, measured with a Malassez counting chamber (n=6). Brown-Forsythe and Welch ANOVA test: **p<0,01. ( J ) Kinetics of Mitosox Green fluorescence in H9C2 treated or not with iCT, S3QEL2, or a combination of S3QEL2 and iCT. One-way ANOVA: ns; not significant. ( K ) Histogram of viable H9C2 cell counts, comparing untreated cells to those treated with iCT, S1QEL1, or a combination of iCT and S1QEL1, measured with a Malassez counting chamber (n=6). Brown-Forsythe and Welch ANOVA test: *p<0,05; ***p<0,001. ( L ) Kinetics of Mitosox Green fluorescence before and after pre-treating H9C2 cells with S1QEL1 followed by iCT treatment, or after iCT treatment alone (n=5) One-way ANOVA: *p<0.05.
    Fluorescence Intensity, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+intensity+analysis/bio_rxiv__2024__12__20__629711-197-5-16?v=Sartorius+AG
    Average 99 stars, based on 1 article reviews
    fluorescence intensity - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    99
    Tecan Systems quantitative fluorescence intensity analysis
    ( A ) Basal oxygen consumption rate measured by Seahorse MitoStress Test in untreated H9C2 cells or those treated with iCT, malonate, or their combination (n=4) Brown-Forsythe and Welch ANOVA test: ***p<0,001. ( B ) Maximum oxygen consumption rate measured by Seahorse MitoStress Test in H9C2 either untreated or treated with iCT, malonate, or the combination of iCT and malonate (Combo) for 24 hours (n=4) Brown-Forsythe and Welch ANOVA test. ( C ) ATP production measured by Seahorse MitoStress Test in H9C2 cells either untreated or treated with iCT, malonate, or the combination of iCT and malonate (Combo) for 24 hours (n=6). Friedman Test, *p<0,05; **p<0,01. ( D ) Histogram of NAD + concentration in H9C2 cells, either untreated or treated with iCT, malonate, or their combination (n=6). One-way ANOVA. ( E ) Histogram of NADH concentration in H9C2 cells, either untreated or treated with iCT, malonate, or their combination (n=6). One-way ANOVA: **p<0,01. ( F ) Histogram of succinate concentration in H9C2 cells treated with iCT, Malonate, or the combination of Malonate and iCT, normalized to control cells (n=4). One sample t-test, *p<0,05; **p<0.01. ( G ) Kinetics and ( H ) Histogram quantification of Mitosox Green <t>fluorescence</t> representing mitochondrial ROS before and after pre-treating H9C2 cells with malonate, followed by iCT treatment, or after iCT treatment alone (n=6). One-way ANOVA: *p<0.05; **p<0.01 ( I ) Histogram of viable H9C2 cell counts, comparing untreated cells to those treated with iCT, S3QEL2, or a combination of iCT and S3QEL2, measured with a Malassez counting chamber (n=6). Brown-Forsythe and Welch ANOVA test: **p<0,01. ( J ) Kinetics of Mitosox Green fluorescence in H9C2 treated or not with iCT, S3QEL2, or a combination of S3QEL2 and iCT. One-way ANOVA: ns; not significant. ( K ) Histogram of viable H9C2 cell counts, comparing untreated cells to those treated with iCT, S1QEL1, or a combination of iCT and S1QEL1, measured with a Malassez counting chamber (n=6). Brown-Forsythe and Welch ANOVA test: *p<0,05; ***p<0,001. ( L ) Kinetics of Mitosox Green fluorescence before and after pre-treating H9C2 cells with S1QEL1 followed by iCT treatment, or after iCT treatment alone (n=5) One-way ANOVA: *p<0.05.
    Quantitative Fluorescence Intensity Analysis, supplied by Tecan Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fluorescence+intensity+analysis/pmc11899522-189-0-8?v=Tecan+Systems
    Average 99 stars, based on 1 article reviews
    quantitative fluorescence intensity analysis - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Basal oxygen consumption rate measured by Seahorse MitoStress Test in untreated H9C2 cells or those treated with iCT, malonate, or their combination (n=4) Brown-Forsythe and Welch ANOVA test: ***p<0,001. ( B ) Maximum oxygen consumption rate measured by Seahorse MitoStress Test in H9C2 either untreated or treated with iCT, malonate, or the combination of iCT and malonate (Combo) for 24 hours (n=4) Brown-Forsythe and Welch ANOVA test. ( C ) ATP production measured by Seahorse MitoStress Test in H9C2 cells either untreated or treated with iCT, malonate, or the combination of iCT and malonate (Combo) for 24 hours (n=6). Friedman Test, *p<0,05; **p<0,01. ( D ) Histogram of NAD + concentration in H9C2 cells, either untreated or treated with iCT, malonate, or their combination (n=6). One-way ANOVA. ( E ) Histogram of NADH concentration in H9C2 cells, either untreated or treated with iCT, malonate, or their combination (n=6). One-way ANOVA: **p<0,01. ( F ) Histogram of succinate concentration in H9C2 cells treated with iCT, Malonate, or the combination of Malonate and iCT, normalized to control cells (n=4). One sample t-test, *p<0,05; **p<0.01. ( G ) Kinetics and ( H ) Histogram quantification of Mitosox Green fluorescence representing mitochondrial ROS before and after pre-treating H9C2 cells with malonate, followed by iCT treatment, or after iCT treatment alone (n=6). One-way ANOVA: *p<0.05; **p<0.01 ( I ) Histogram of viable H9C2 cell counts, comparing untreated cells to those treated with iCT, S3QEL2, or a combination of iCT and S3QEL2, measured with a Malassez counting chamber (n=6). Brown-Forsythe and Welch ANOVA test: **p<0,01. ( J ) Kinetics of Mitosox Green fluorescence in H9C2 treated or not with iCT, S3QEL2, or a combination of S3QEL2 and iCT. One-way ANOVA: ns; not significant. ( K ) Histogram of viable H9C2 cell counts, comparing untreated cells to those treated with iCT, S1QEL1, or a combination of iCT and S1QEL1, measured with a Malassez counting chamber (n=6). Brown-Forsythe and Welch ANOVA test: *p<0,05; ***p<0,001. ( L ) Kinetics of Mitosox Green fluorescence before and after pre-treating H9C2 cells with S1QEL1 followed by iCT treatment, or after iCT treatment alone (n=5) One-way ANOVA: *p<0.05.

    Journal: bioRxiv

    Article Title: Intensive Chemotherapy Induces Cardiotoxicity via Reverse Electron Transport

    doi: 10.1101/2024.12.20.629711

    Figure Lengend Snippet: ( A ) Basal oxygen consumption rate measured by Seahorse MitoStress Test in untreated H9C2 cells or those treated with iCT, malonate, or their combination (n=4) Brown-Forsythe and Welch ANOVA test: ***p<0,001. ( B ) Maximum oxygen consumption rate measured by Seahorse MitoStress Test in H9C2 either untreated or treated with iCT, malonate, or the combination of iCT and malonate (Combo) for 24 hours (n=4) Brown-Forsythe and Welch ANOVA test. ( C ) ATP production measured by Seahorse MitoStress Test in H9C2 cells either untreated or treated with iCT, malonate, or the combination of iCT and malonate (Combo) for 24 hours (n=6). Friedman Test, *p<0,05; **p<0,01. ( D ) Histogram of NAD + concentration in H9C2 cells, either untreated or treated with iCT, malonate, or their combination (n=6). One-way ANOVA. ( E ) Histogram of NADH concentration in H9C2 cells, either untreated or treated with iCT, malonate, or their combination (n=6). One-way ANOVA: **p<0,01. ( F ) Histogram of succinate concentration in H9C2 cells treated with iCT, Malonate, or the combination of Malonate and iCT, normalized to control cells (n=4). One sample t-test, *p<0,05; **p<0.01. ( G ) Kinetics and ( H ) Histogram quantification of Mitosox Green fluorescence representing mitochondrial ROS before and after pre-treating H9C2 cells with malonate, followed by iCT treatment, or after iCT treatment alone (n=6). One-way ANOVA: *p<0.05; **p<0.01 ( I ) Histogram of viable H9C2 cell counts, comparing untreated cells to those treated with iCT, S3QEL2, or a combination of iCT and S3QEL2, measured with a Malassez counting chamber (n=6). Brown-Forsythe and Welch ANOVA test: **p<0,01. ( J ) Kinetics of Mitosox Green fluorescence in H9C2 treated or not with iCT, S3QEL2, or a combination of S3QEL2 and iCT. One-way ANOVA: ns; not significant. ( K ) Histogram of viable H9C2 cell counts, comparing untreated cells to those treated with iCT, S1QEL1, or a combination of iCT and S1QEL1, measured with a Malassez counting chamber (n=6). Brown-Forsythe and Welch ANOVA test: *p<0,05; ***p<0,001. ( L ) Kinetics of Mitosox Green fluorescence before and after pre-treating H9C2 cells with S1QEL1 followed by iCT treatment, or after iCT treatment alone (n=5) One-way ANOVA: *p<0.05.

    Article Snippet: To measure mitochondrial ROS production, fluorescence intensity was monitored using the Incucyte SX G/O/NIR Optical Module (Sartorius) with a 20X objective.

    Techniques: Concentration Assay, Control, Fluorescence